← Back to Search

Behavioral Intervention

MAT+ both CBT and CRS/Peer Support Specialist for Opioid Use Disorder

N/A

Recruiting

Led By David S Festinger, Ph.D.

Research Sponsored by Public Health Management Corporation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline and 3,6,9, 12-month assessments

Awards & highlights

Study Summary

This trial aims to find the best ways to help people with opioid use disorder by combining medication with different types of therapy. The researchers are working with former patients to understand what treatments work best for different individuals

Who is the study for?

This trial is for individuals with Opioid Use Disorder who are currently on medication-assisted treatment. It's designed to explore the benefits of adding psychosocial support to their regimen. Participants should be interested in how different psychological treatments can complement their current therapy.Check my eligibility

What is being tested?

The study is testing various forms of psychosocial treatment as a component of medication-assisted therapy for opioid addiction. The aim is to find out which approaches work best for different patients, moving away from generic treatments and towards more personalized care.See study design

What are the potential side effects?

Since the interventions being studied are psychosocial in nature, they may include emotional distress or discomfort during sessions, potential changes in mood or behavior, but no physical side effects like those associated with medications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline and 3,6,9, 12-month assessments

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline and 3,6,9, 12-month assessments

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 3,6,9, 12-month assessments for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in urinalysis-confirmed opioid use from baseline through one year post-study entry

Secondary outcome measures

Changes in ED utilization from baseline to one year post-study entry

Changes in multidimensional problem severity from baseline through one year post-study entry

Changes in opioid overdose rates

+4 more

Other outcome measures

Job satisfaction and stress

Trial Design

4Treatment groups

Active Control

Group I: MAT+ both CBT and CRS/Peer Support SpecialistActive Control1 Intervention

Those randomized to MAT+ office-based CBT will receive office-based buprenorphine treatment along with office-based CBT and a CRS.

Group II: MAT- OBOTActive Control1 Intervention

Those randomized to MAT standard of care will continue to receive standard office-based buprenorphine treatment.

Group III: MAT+ CRS/Peer Support SpecialistActive Control1 Intervention

Those randomized to MAT+ office-based CBT will receive office-based buprenorphine treatment along with a CRS.

Group IV: MAT+ office-based CBTActive Control1 Intervention

Those randomized to MAT+ office-based CBT will receive office-based buprenorphine treatment along with office-based CBT.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Philadelphia College of Osteopathic MedicineOTHER

9 Previous Clinical Trials

917 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

551 Previous Clinical Trials

29,997,018 Total Patients Enrolled

Boston UniversityOTHER

455 Previous Clinical Trials

9,941,185 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How large is the participant pool for this particular research endeavor?

"Indeed, the details available on clinicaltrials.gov state that this particular research endeavor is actively seeking suitable participants. This study was initially disclosed on March 13th, 2020, and underwent its latest update on April 5th, 2024. A total of 440 individuals are sought for inclusion at a single designated location."

Answered by AI

Are researchers currently enrolling participants for this clinical study?

"According to the details available on clinicaltrials.gov, recruitment for this research endeavor is ongoing. The trial was initially published on March 13th, 2020 and last revised on April 5th, 2024."

Answered by AI

Recent research and studies

The American Journal of MedicineJournal

A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine

Fiellin, David A., Declan T. Barry, Lynn E. Sullivan, Christopher J. Cutter, Brent A. Moore, Patrick G. O'Connor, and Richard S. Schottenfeld. 2013. “A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine”. The American Journal of Medicine. Elsevier BV. doi:10.1016/j.amjmed.2012.07.005.

AddictionJournal

Comparison of Behavioral Treatment Conditions in Buprenorphine Maintenance

Ling, Walter, Maureen Hillhouse, Alfonso Ang, Jessica Jenkins, and Jacqueline Fahey. 2013. “Comparison of Behavioral Treatment Conditions in Buprenorphine Maintenance”. Addiction. Wiley. doi:10.1111/add.12266.

Archives of General PsychiatryJournal

Adjunctive Counseling During Brief and Extended Buprenorphine-naloxone Treatment for Prescription Opioid Dependence

Weiss, Roger D.. 2011. “Adjunctive Counseling During Brief and Extended Buprenorphine-naloxone Treatment for Prescription Opioid Dependence”. Archives of General Psychiatry. American Medical Association (AMA). doi:10.1001/archgenpsychiatry.2011.121.

The American Journal on AddictionsJournal